The levels of Shank3 protein in the prefrontal cortex were dramatically reduced already in the adult group, resulting in a significant difference in the mean o.d. in this group in comparison with the adult and aged/AD groups (Figure 14C, top row, left graph). This evidence concerns the gene SHANK3 and Alzheimer disease.